Addressing the Role of Violence on HIV Care and Viral Suppression (R01 Clinical Trial Optional) | RFA MH 20 200

Opportunity Information: Apply for RFA MH 20 200

The National Institutes of Health (NIH) funding opportunity announcement titled "Addressing the Role of Violence on HIV Care and Viral Suppression (R01 Clinical Trial Optional)" (Funding Opportunity Number RFA-MH-20-200) supports research that examines how exposure to violence affects key HIV outcomes and then uses that knowledge to design and evaluate new approaches to improve care. The focus is on understanding and reducing the negative impact that violence can have on engagement and retention in HIV care, adherence to HIV medications, and achievement of viral suppression. In addition to generating stronger evidence about these relationships, the FOA explicitly encourages the development and testing of novel interventions intended to improve HIV-related outcomes for people who have experienced violence, with the flexibility that clinical trials are optional under this R01 mechanism.

This is a discretionary grant program under the NIH, categorized in the health funding activity area, and tied to CFDA numbers 93.242 and 93.313. The opportunity uses the R01 research project grant mechanism, which typically supports substantial, hypothesis-driven projects that can combine observational research (to clarify mechanisms and pathways) with intervention development and evaluation (to address identified barriers). Because the announcement is "Clinical Trial Optional," applicants may propose studies that do not involve a clinical trial (for example, longitudinal cohort studies, mixed-methods research, measurement development, or implementation-focused observational work), or they may include a clinical trial component if it is necessary to test an intervention aimed at improving adherence, retention, or viral suppression among survivors of violence.

The eligible applicant pool is broad and includes many types of public and private organizations. Eligible entities include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; and Native American tribal organizations that are not federally recognized tribal governments. The FOA also allows applications from public housing authorities and Indian housing authorities, nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education), for-profit organizations (other than small businesses), and small businesses. Beyond these standard categories, the announcement highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, regional organizations, tribal governments that are not federally recognized, and even non-U.S. entities (foreign organizations). This wide eligibility is designed to encourage proposals from institutions that are closely connected to communities most affected by HIV and violence and that can conduct culturally grounded, context-specific research.

Key administrative details included in the source information are that the FOA was created on 2019-01-29 and had an original closing date of 2019-04-10. The listed award ceiling is $500,000, indicating an upper limit on the amount of funding expected per award (typically per year, depending on NIH-specific budget rules and the FOA language). The number of expected awards is not specified in the provided text. Overall, the opportunity is aimed at strengthening the evidence base on how violence intersects with HIV treatment and outcomes, while also moving beyond description to practical, testable solutions that can improve medication adherence, keep people connected to care, and help more individuals achieve and maintain viral suppression after experiences of violence.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Addressing the Role of Violence on HIV Care and Viral Suppression (R01 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.313.
• This funding opportunity was created on 2019-01-29.
• Applicants must submit their applications by 2019-04-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $500,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA MH 20 200

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: